chr4-2818270-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The ENST00000511747.6(SH3BP2):​c.47C>T​(p.Ala16Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 1,013,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000092 ( 0 hom. )

Consequence

SH3BP2
ENST00000511747.6 missense

Scores

2
1
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:1

Conservation

PhyloP100: -0.192
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1240581).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000816 (12/146984) while in subpopulation AFR AF= 0.00022 (9/40976). AF 95% confidence interval is 0.000114. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SH3BP2NM_001122681.2 linkuse as main transcriptc.-4-2344C>T intron_variant ENST00000503393.8
SH3BP2NM_001145856.2 linkuse as main transcriptc.47C>T p.Ala16Val missense_variant 1/13
SH3BP2NM_001145855.2 linkuse as main transcriptc.81-2344C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SH3BP2ENST00000503393.8 linkuse as main transcriptc.-4-2344C>T intron_variant 1 NM_001122681.2 P2P78314-1

Frequencies

GnomAD3 genomes
AF:
0.0000817
AC:
12
AN:
146882
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000303
Gnomad OTH
AF:
0.000495
GnomAD4 exome
AF:
0.00000923
AC:
8
AN:
866930
Hom.:
0
Cov.:
28
AF XY:
0.00000744
AC XY:
3
AN XY:
403244
show subpopulations
Gnomad4 AFR exome
AF:
0.000303
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000383
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000816
AC:
12
AN:
146984
Hom.:
0
Cov.:
32
AF XY:
0.0000699
AC XY:
5
AN XY:
71552
show subpopulations
Gnomad4 AFR
AF:
0.000220
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000303
Gnomad4 OTH
AF:
0.000490

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

SH3BP2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJan 02, 2024The SH3BP2 c.47C>T variant is predicted to result in the amino acid substitution p.Ala16Val. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
8.8
DANN
Uncertain
0.98
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0070
N
LIST_S2
Benign
0.34
T
M_CAP
Pathogenic
0.67
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.90
T
MutationTaster
Benign
1.0
D;D;D;D;D;N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.16
Sift
Benign
0.19
T
Vest4
0.10
MutPred
0.22
Loss of helix (P = 0.0304);
MVP
0.42
MPC
0.16
ClinPred
0.10
T
GERP RS
0.55
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs868817457; hg19: chr4-2819997; API